Hegde P, Aragaw W, Cole M, Jachak G, Ragunathan P, Sharma S
Bioorg Med Chem. 2022; 74:117046.
PMID: 36228522
PMC: 10551889.
DOI: 10.1016/j.bmc.2022.117046.
Cole M, Howe M, Buonomo J, Sharma S, Lamont E, Brody S
Chemistry. 2022; 28(51):e202200995.
PMID: 35697660
PMC: 9474573.
DOI: 10.1002/chem.202200995.
Mech P, Makowski M, Kawiak A, Chylewska A
RSC Adv. 2022; 10(67):40673-40688.
PMID: 35519225
PMC: 9059145.
DOI: 10.1039/d0ra06239a.
Thiede J, Dillon N, Howe M, Aflakpui R, Modlin S, Hoffner S
mBio. 2022; 13(1):e0043921.
PMID: 35100871
PMC: 8805019.
DOI: 10.1128/mbio.00439-21.
Juhas M, Kucerova L, Horacek O, Jandourek O, Kubicek V, Konecna K
Molecules. 2020; 25(7).
PMID: 32230728
PMC: 7181131.
DOI: 10.3390/molecules25071518.
Design, synthesis and evaluation of biological activities of some novel anti-TB agents with bio-reducible functional group.
Khani-Meinagh H, Mostafavi H, Reiling N, Mahdavi M, Zarrini G
Bioimpacts. 2019; 9(4):199-209.
PMID: 31799156
PMC: 6879708.
DOI: 10.15171/bi.2019.25.
Why Wait? The Case for Treating Tuberculosis with Inhaled Drugs.
Braunstein M, Hickey A, Ekins S
Pharm Res. 2019; 36(12):166.
PMID: 31650321
PMC: 7607971.
DOI: 10.1007/s11095-019-2704-6.
Design and Characterization of Inulin Conjugate for Improved Intracellular and Targeted Delivery of Pyrazinoic Acid to Monocytes.
Afinjuomo F, Barclay T, Parikh A, Song Y, Chung R, Wang L
Pharmaceutics. 2019; 11(5).
PMID: 31121836
PMC: 6572292.
DOI: 10.3390/pharmaceutics11050243.
Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.
Larsen E, Johnson R
Drug Dev Res. 2018; 80(1):33-47.
PMID: 30302779
PMC: 6377847.
DOI: 10.1002/ddr.21468.
Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
Montgomery S, Young E, Durham P, Zulauf K, Rank L, Miller B
PLoS One. 2018; 13(9):e0204495.
PMID: 30261007
PMC: 6160074.
DOI: 10.1371/journal.pone.0204495.
Ester-prodrugs of ethambutol control its antibacterial activity and provide rapid screening for mycobacterial hydrolase activity.
Larsen E, Stephens D, Clarke N, Johnson R
Bioorg Med Chem Lett. 2017; 27(19):4544-4547.
PMID: 28882482
PMC: 5607105.
DOI: 10.1016/j.bmcl.2017.08.057.
Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis.
Young E, Perkowski E, Malik S, Hayden J, Durham P, Zhong L
Pharm Res. 2016; 33(10):2495-505.
PMID: 27351427
DOI: 10.1007/s11095-016-1974-5.
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
Lanoix J, Tasneen R, OBrien P, Sarathy J, Safi H, Pinn M
Antimicrob Agents Chemother. 2016; 60(7):4197-205.
PMID: 27139472
PMC: 4914615.
DOI: 10.1128/AAC.03085-15.
A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animals.
Durham P, Young E, Braunstein M, Welch J, Hickey A
Int J Pharm. 2016; 514(2):384-391.
PMID: 27130363
PMC: 9347698.
DOI: 10.1016/j.ijpharm.2016.04.063.
Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
Pires D, Valente E, Simoes M, Carmo N, Testa B, Constantino L
Antimicrob Agents Chemother. 2015; 59(12):7693-9.
PMID: 26438493
PMC: 4649235.
DOI: 10.1128/AAC.00936-15.
Synthesis and evaluation of a pyrazinoic acid prodrug in Mycobacterium tuberculosis.
Fernandes J, Pavan F, Fujimura Leite C, Andres Felli V
Saudi Pharm J. 2014; 22(4):376-80.
PMID: 25161383
PMC: 4142361.
DOI: 10.1016/j.jsps.2013.12.005.
A Computational Study of Cytotoxicity of Substituted Amides of Pyrazine- 2-carboxylic acids Using QSAR and DFT Based Molecular Surface Electrostatic Potential.
Hosseini S, Monajjemi M, Rajaeian E, Haghgu M, Salari A, Gholami M
Iran J Pharm Res. 2014; 12(4):745-50.
PMID: 24523754
PMC: 3920709.
Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Ahmad Z, Tyagi S, Minkowsk A, Almeida D, Nuermberger E, Peck K
Indian J Med Res. 2013; 136(5):808-14.
PMID: 23287128
PMC: 3573602.
Emergence of potential superbug mycobacterium tuberculosis, lessons from new delhi mutant-1 bacterial strains.
Nazir T, Abraham S, Islam A
Int J Health Sci (Qassim). 2012; 6(1):87-94.
PMID: 23267308
PMC: 3523789.
DOI: 10.12816/0005977.
The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.
Mendez S, Traslavina R, Hinchman M, Huang L, Green P, Cynamon M
Antimicrob Agents Chemother. 2009; 53(12):5114-21.
PMID: 19770283
PMC: 2786368.
DOI: 10.1128/AAC.01146-09.